Zhu Longkun, He Pingnian
Dept. of Physiology and Pharmacology, School of Medicine, Health Sciences Center, West Virginia Univ., Morgantown, WV 26506-9229, USA.
Am J Physiol Heart Circ Physiol. 2005 Jun;288(6):H2869-77. doi: 10.1152/ajpheart.01080.2004. Epub 2005 Jan 21.
We have demonstrated that inhibition of NO synthase (NOS) in endothelial cells by either the NOS inhibitor N(omega)-monomethyl-l-arginine (l-NMMA) or the internalization of caveolin-1 scaffolding domain attenuated platelet-activating factor (PAF)-induced increases in microvessel permeability (Am J Physiol Heart Circ Physiol 286: H195-H201, 2004) indicating the involvement of an NO-dependent signaling pathway. To investigate whether an increase in endothelial cytoplasmic Ca(2+) concentration (Ca(2+)) is the initiating event and Ca(2+)-dependent NO production is crucial for permeability increases, PAF (10 nM)-induced changes in endothelial Ca(2+) and NO production were measured in individually perfused rat mesenteric venular microvessels via fluorescence microscopy. When venular microvessels were exposed to PAF, endothelial Ca(2+) increased from 69 +/- 8 nM to a peak value of 374 +/- 26 nM within 3 min and then declined to a sustained level at 190 +/- 12 nM after 15 min. Inhibition of NOS did not modify PAF-induced increases in endothelial Ca(2+). PAF-induced NO production was visualized and quantified at cellular levels in individually perfused microvessels using 4,5-diaminofluorescein diacetate and fluorescence imaging. Increased fluorescence intensity (FI), which is an indication of increased NO production, occurred in 75 +/- 7% of endothelial cells in each vessel. The mean maximum FI increase was 140 +/- 7% of baseline value. This increased FI was abolished by pretreatment of the vessel with l-NMMA and attenuated in the absence of extracellular Ca(2+). These results provide direct evidence from intact microvessels that increased endothelial Ca(2+) is the initial signal that activates endothelial NOS, and the subsequent increased NO production contributes to PAF-induced increases in microvessel permeability.
我们已经证明,通过一氧化氮合酶(NOS)抑制剂N(ω)-单甲基-L-精氨酸(L-NMMA)或小窝蛋白-1支架结构域的内化来抑制内皮细胞中的NOS,可减弱血小板活化因子(PAF)诱导的微血管通透性增加(《美国生理学杂志:心脏和循环生理学》286:H195-H201,2004),这表明存在一条依赖一氧化氮的信号通路。为了研究内皮细胞质钙离子浓度([Ca²⁺]i)的升高是否是起始事件,以及钙离子依赖性一氧化氮生成对于通透性增加是否至关重要,通过荧光显微镜在单独灌注的大鼠肠系膜静脉微血管中测量了PAF(10 nM)诱导的内皮[Ca²⁺]i和一氧化氮生成的变化。当静脉微血管暴露于PAF时,内皮[Ca²⁺]i在3分钟内从69±8 nM增加到峰值374±26 nM,然后在15分钟后降至190±12 nM的持续水平。抑制NOS并没有改变PAF诱导的内皮[Ca²⁺]i增加。使用4,5-二氨基荧光素二乙酸酯和荧光成像在单独灌注的微血管中在细胞水平上可视化并定量PAF诱导的一氧化氮生成。荧光强度(FI)增加,这表明一氧化氮生成增加,在每个血管中75±7%的内皮细胞中出现。平均最大FI增加为基线值的140±7%。用L-NMMA预处理血管可消除这种增加的FI,而在没有细胞外钙离子的情况下则减弱。这些结果从完整的微血管中提供了直接证据,即内皮[Ca²⁺]i升高是激活内皮NOS的初始信号,随后增加的一氧化氮生成导致PAF诱导的微血管通透性增加。